Comparison Chart Oragenics, Inc.

Stocks

OGEN

US6840236094

Biotechnology & Medical Research

Market Closed - NYSE 23:10:00 23/10/2026 +03			5-day change	1st Jan Change
0.4170 ^USD	+2.90%		-4.09%	-46.74%

08-13	Oragenics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-07	Oragenics Achieves Full Activation of Australian Phase IIa Trial Network for ONP-002 and Advances U.S. Regulatory Pathway	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	ORAGENICS, INC.	Bio Therapeutic Drugs	+2.90%	-4.09%	-46.74%	-68.40%	-99.96%	1.88M